Keywords: fda, approves, novantrone, secondary, progressive, multiple, sclerosis

FDA approves Novantrone for secondary progressive multiple sclerosis

Article | 16 October 2000

Print This

Immunex' Novantrone (mitoxantrone for injection) has become the firstdrug to be approved by the US Food and Drug Administration for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in